Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neoplasms
|
1644 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.100 | 0.900 | 10 | 2006 | 2017 | |||||
Carcinoma of lung
|
1204 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Malignant neoplasm of lung
|
1142 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Primary malignant neoplasm of lung
|
981 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Breast Carcinoma
|
2793 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.100 | 0.733 | 15 | 2007 | 2017 | |||||
Malignant neoplasm of breast
|
3417 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.100 | 0.733 | 15 | 2007 | 2017 | |||||
Malignant Neoplasms
|
1641 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2007 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.040 | 1.000 | 4 | 2007 | 2019 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2007 | 2011 | |||||
Renal Cell Carcinoma
|
288 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2007 | 2011 | |||||
Chronic Lymphocytic Leukemia
|
291 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1 | 2007 | 2007 | ||||||
Gastric Cardia Adenocarcinoma
|
11 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Gastric Cardia Carcinoma
|
13 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Giant Cell Arteritis
|
78 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Liver carcinoma
|
942 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.050 | 0.800 | 5 | 2008 | 2017 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2008 | 2014 | |||||
Hepatitis B
|
519 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Premenopausal breast cancer
|
18 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Transitional cell carcinoma of bladder
|
158 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Treatment related acute myeloid leukaemia
|
4 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
melanoma
|
515 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2009 | 2014 | |||||
Squamous cell carcinoma
|
257 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.020 | 1.000 | 2 | 2009 | 2009 | |||||
Carcinoma, Basal Cell
|
91 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Childhood Osteosarcoma
|
151 | 0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2009 | 2009 |